Total Payments
$41,170
2024 Payments
$3,702
Companies
25
Transactions
350
Medicare Patients
2,636
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$29,800 (72.4%)
Food & Beverage$7,515 (18.3%)
Consulting$2,225 (5.4%)
Travel$1,449 (3.5%)
Education$181.38 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,800 | 17 | 72.4% |
| Food and Beverage | $7,515 | 314 | 18.3% |
| Consulting Fee | $2,225 | 2 | 5.4% |
| Travel and Lodging | $1,449 | 12 | 3.5% |
| Education | $181.38 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $21,186 | 93 | $0 (2024) |
| Amgen Inc. | $10,639 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $3,121 | 23 | $0 (2022) |
| Genentech USA, Inc. | $2,111 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,191 | 67 | $0 (2024) |
| ALK-Abello, Inc | $714.82 | 5 | $0 (2018) |
| Optinose US, Inc. | $290.91 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $253.61 | 14 | $0 (2024) |
| GENZYME CORPORATION | $242.93 | 13 | $0 (2024) |
| PFIZER INC. | $219.39 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,702 | 54 | AstraZeneca Pharmaceuticals LP ($2,679) |
| 2023 | $13,318 | 65 | AstraZeneca Pharmaceuticals LP ($8,066) |
| 2022 | $15,992 | 73 | AstraZeneca Pharmaceuticals LP ($9,549) |
| 2021 | $590.55 | 36 | AstraZeneca Pharmaceuticals LP ($117.09) |
| 2020 | $2,219 | 29 | Genentech USA, Inc. ($1,765) |
| 2019 | $444.79 | 20 | AstraZeneca Pharmaceuticals LP ($258.66) |
| 2018 | $2,553 | 35 | Teva Pharmaceuticals USA, Inc. ($1,713) |
| 2017 | $2,352 | 38 | Teva Pharmaceuticals USA, Inc. ($1,262) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Immunology | ||||||
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Inflammation | ||||||
| 11/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $80.65 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: GENETIC DISEASE | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Inflammation | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 07/24/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: Immunology | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 740 | 16,173 | $1.2M | $358,975 |
| 2022 | 15 | 725 | 13,019 | $957,115 | $290,940 |
| 2021 | 14 | 720 | 15,944 | $1.0M | $317,794 |
| 2020 | 11 | 451 | 3,837 | $139,791 | $35,360 |
Total Patients
2,636
Total Services
48,973
Medicare Billing
$1.0M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 15 | 10,175 | $967,950 | $297,245 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 250 | $40,000 | $15,143 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 102 | $24,480 | $9,462 | 38.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 83 | 2,816 | $45,056 | $7,655 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 100 | 100 | $20,500 | $6,956 | 33.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 22 | 570 | $28,500 | $5,682 | 19.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 491 | $31,265 | $5,263 | 16.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 34 | 420 | $16,800 | $3,199 | 19.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 66 | 542 | $13,550 | $3,117 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,650 | $1,618 | 34.8% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 11 | 324 | $6,480 | $1,158 | 17.9% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 11 | 84 | $4,620 | $1,080 | 23.4% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 13 | 149 | $5,215 | $1,008 | 19.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 79 | 124 | $1,240 | $227.70 | 18.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 11 | $935.00 | $162.40 | 17.4% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 16 | 7,861 | $748,050 | $233,662 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 267 | $42,720 | $16,337 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 128 | 128 | $26,240 | $10,353 | 39.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 73 | 2,574 | $41,184 | $7,800 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 59 | $14,160 | $4,566 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 404 | $26,260 | $4,413 | 16.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 16 | 311 | $15,550 | $3,506 | 22.5% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 62 | 536 | $13,400 | $3,363 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,340 | $1,742 | 40.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 27 | 223 | $8,904 | $1,664 | 18.7% |
About Dr. Todd Rambasek, MD
Dr. Todd Rambasek, MD is a Allergy & Immunology healthcare provider based in Sandusky, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093814220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Rambasek, MD has received a total of $41,170 in payments from pharmaceutical and medical device companies, with $3,702 received in 2024. These payments were reported across 350 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,800).
As a Medicare-enrolled provider, Rambasek has provided services to 2,636 Medicare beneficiaries, totaling 48,973 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Sandusky, OH
- Active Since 09/22/2006
- Last Updated 03/17/2018
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093814220
Products in Payments
- TEZSPIRE (Biological) $30,140
- Xolair (Biological) $2,100
- QVAR (Drug) $1,713
- NUCALA (Biological) $1,008
- PROAIR (Drug) $752.38
- Odactra (Biological) $703.23
- DUPIXENT (Biological) $578.44
- FASENRA (Drug) $508.98
- PROAIR RESPICLICK (Drug) $500.00
- Xhance (Drug) $290.91
- SYMBICORT (Drug) $253.18
- FASENRA (Biological) $246.26
- AIRSUPRA (Drug) $203.72
- EUCRISA (Drug) $200.08
- Hizentra (Biological) $169.70
- TAKHZYRO (Biological) $136.96
- XOLAIR (Drug) $107.08
- TRELEGY ELLIPTA (Drug) $97.61
- BREZTRI (Drug) $91.92
- XOLAIR (Biological) $87.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.